Biotech · Public company · Plymouth Meeting, PA, US
Inovio Pharmaceuticals, Inc.
Ticker INO · SEC CIK 0001055726
Track this companyFree. Adds Inovio Pharmaceuticals, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials232 recruiting or active
Pipeline programs39From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availableNo recent cash burn filed
Pipeline39
- CELLECTRA® 2000Phase 3 · Coronavirus InfectionClinicalTrials.gov · fetched Nov 12, 2026
- CELLECTRA™-5PSPPhase 3 · Cervical DysplasiaClinicalTrials.gov · fetched Nov 12, 2026
- Electroporation (EP)Phase 3 · Cervical DysplasiaClinicalTrials.gov · fetched Nov 12, 2026
- INO-4800Phase 3 · Coronavirus InfectionClinicalTrials.gov · fetched Nov 12, 2026
- Medpulser electroporation with BleomycinPhase 3 · Head and Neck CancerClinicalTrials.gov · fetched Nov 12, 2026
- Medpulser Electroporation with BleomycinPhase 3 · Head Neck CancerClinicalTrials.gov · fetched Nov 12, 2026
- Surgical ExcisionPhase 3 · Head Neck CancerClinicalTrials.gov · fetched Nov 12, 2026
- Tumor surgical excisionPhase 3 · Head and Neck CancerClinicalTrials.gov · fetched Nov 12, 2026
- VGX-3100Phase 3 · Cervical DysplasiaClinicalTrials.gov · fetched Nov 12, 2026
- AtezolizumabPhase 2 · Urothelial CarcinomaClinicalTrials.gov · fetched Nov 12, 2026
- CELLECTRA® 2000Phase 2 · Urothelial CarcinomaClinicalTrials.gov · fetched Nov 12, 2026
- CELLECTRA® 2000Phase 2 · Respiratory PapillomatosisClinicalTrials.gov · fetched Nov 12, 2026
- CELLECTRA™ 2000Phase 2 · Vulvar High Grade Squamous Intraepithelial Lesion (HSIL)ClinicalTrials.gov · fetched Nov 12, 2026
- CELLECTRA™ 5PSPPhase 2 · Anal NeoplasmClinicalTrials.gov · fetched Nov 12, 2026
- CELLECTRA™-5PPhase 2 · Cervical CancerClinicalTrials.gov · fetched Nov 12, 2026
- CELLECTRA™-5PPhase 2 · Head and Neck Squamous Cell CancerClinicalTrials.gov · fetched Nov 12, 2026
- CemiplimabPhase 2 · GlioblastomaClinicalTrials.gov · fetched Nov 12, 2026
- Imiquimod 5% CreamPhase 2 · Vulvar High Grade Squamous Intraepithelial Lesion (HSIL)ClinicalTrials.gov · fetched Nov 12, 2026
- INO-3107Phase 2 · Respiratory PapillomatosisClinicalTrials.gov · fetched Nov 12, 2026
- INO-3112Phase 2 · Head and Neck Squamous Cell CancerClinicalTrials.gov · fetched Nov 12, 2026
- INO-3112Phase 2 · Cervical CancerClinicalTrials.gov · fetched Nov 12, 2026
- INO-5401Phase 2 · Urothelial CarcinomaClinicalTrials.gov · fetched Nov 12, 2026
- INO-5401Phase 2 · GlioblastomaClinicalTrials.gov · fetched Nov 12, 2026
- INO-9012Phase 2 · GlioblastomaClinicalTrials.gov · fetched Nov 12, 2026
- INO-9012Phase 2 · Urothelial CarcinomaClinicalTrials.gov · fetched Nov 12, 2026
- Radiation TherapyPhase 2 · GlioblastomaClinicalTrials.gov · fetched Nov 12, 2026
- TemozolomidePhase 2 · GlioblastomaClinicalTrials.gov · fetched Nov 12, 2026
- VGX-3100Phase 2 · Vulvar High Grade Squamous Intraepithelial Lesion (HSIL)ClinicalTrials.gov · fetched Nov 12, 2026
- VGX-3100Phase 2 · Anal NeoplasmClinicalTrials.gov · fetched Nov 12, 2026
- CELLECTRA® 2000Phase 1 · Lassa FeverClinicalTrials.gov · fetched Nov 12, 2026
- INO-1800Phase 1 · Hepatitis BClinicalTrials.gov · fetched Nov 12, 2026
- INO-4201Phase 1 · Ebola VaccineClinicalTrials.gov · fetched Nov 12, 2026
- INO-4201 + INO-9012Phase 1 · Ebola VaccineClinicalTrials.gov · fetched Nov 12, 2026
- INO-4202Phase 1 · Ebola VaccineClinicalTrials.gov · fetched Nov 12, 2026
- INO-4212Phase 1 · Ebola VaccineClinicalTrials.gov · fetched Nov 12, 2026
- INO-4212 + INO-9012Phase 1 · Ebola VaccineClinicalTrials.gov · fetched Nov 12, 2026
- INO-4500Phase 1 · Lassa FeverClinicalTrials.gov · fetched Nov 12, 2026
- INO-9112Phase 1 · Hepatitis BClinicalTrials.gov · fetched Nov 12, 2026
- Nucleos(t)ide Analogue TreatmentPhase 1 · Hepatitis BClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials23
- dMAbs for Prevention of COVID-19PHASE1 · COMPLETED · started May 19, 2022ClinicalTrials.gov NCT05293249 · fetched Nov 12, 2026
- INO 5401 Vaccination in BRCA1/2 Mutation CarriersPHASE1 · ACTIVE_NOT_RECRUITING · started Apr 20, 2021ClinicalTrials.gov NCT04367675 · fetched Nov 12, 2026
- Safety, Immunogenicity, and Efficacy of INO-4800 for COVID-19 in Adults at High Risk of SARS-CoV-2 ExposurePHASE2_PHASE3 · TERMINATED · started Nov 30, 2020ClinicalTrials.gov NCT04642638 · fetched Nov 12, 2026
- INO-3107 With Electroporation (EP) in Participants With HPV-6- and/or HPV-11-Associated Recurrent Respiratory Papillomatosis (RRP)PHASE1_PHASE2 · COMPLETED · started Oct 7, 2020ClinicalTrials.gov NCT04398433 · fetched Nov 12, 2026
- Safety, Tolerability and Immunogenicity of INO-4800 for COVID-19 in Healthy VolunteersPHASE1 · COMPLETED · started Apr 3, 2020ClinicalTrials.gov NCT04336410 · fetched Nov 12, 2026
- Platform Study for Prostate Researching Translational Endpoints Correlated to Response to Inform Use of Novel CombinationsPHASE1 · COMPLETED · started Jun 21, 2019ClinicalTrials.gov NCT03835533 · fetched Nov 12, 2026
- Safety, Tolerability and Immunogenicity of INO-4500 in Healthy VolunteersPHASE1 · COMPLETED · started May 9, 2019ClinicalTrials.gov NCT03805984 · fetched Nov 12, 2026
- REVEAL 2 Trial (Evaluation of VGX-3100 and Electroporation for the Treatment of Cervical HSIL)PHASE3 · COMPLETED · started Feb 28, 2019ClinicalTrials.gov NCT03721978 · fetched Nov 12, 2026
- A Study of INO-A002 in Healthy Dengue Virus-naive AdultsPHASE1 · COMPLETED · started Feb 7, 2019ClinicalTrials.gov NCT03831503 · fetched Nov 12, 2026
- Therapeutic Vaccination in Treated HIV DiseasePHASE1_PHASE2 · COMPLETED · started Aug 1, 2018ClinicalTrials.gov NCT03606213 · fetched Nov 12, 2026
- INO-5401 + INO-9012 in Combination With Atezolizumab in Locally Advanced Unresectable or Metastatic/Recurrent Urothelial CarcinomaPHASE1_PHASE2 · COMPLETED · started Jul 24, 2018ClinicalTrials.gov NCT03502785 · fetched Nov 12, 2026
- INO-5401 and INO-9012 Delivered by Electroporation (EP) in Combination With Cemiplimab (REGN2810) in Newly-Diagnosed Glioblastoma (GBM)PHASE1_PHASE2 · ACTIVE_NOT_RECRUITING · started May 31, 2018ClinicalTrials.gov NCT03491683 · fetched Nov 12, 2026
- VGX-3100 Delivered Intramuscularly (IM) Followed by Electroporation (EP) for the Treatment of HPV-16 and/or HPV-18 Related Anal or Anal/Peri-Anal, High Grade Squamous Intraepithelial Lesion (HSIL) in Individuals Seronegative for Human Immunodeficiency Virus (HIV)-1/2PHASE2 · COMPLETED · started May 15, 2018ClinicalTrials.gov NCT03499795 · fetched Nov 12, 2026
- Evaluation of VGX-3100 and Electroporation Alone or in Combination With Imiquimod for the Treatment of HPV-16 and/or HPV-18 Related Vulvar HSIL (Also Referred as: VIN 2 or VIN 3)PHASE2 · COMPLETED · started Aug 31, 2017ClinicalTrials.gov NCT03180684 · fetched Nov 12, 2026
- REVEAL 1 (Evaluation of VGX-3100 and Electroporation for the Treatment of Cervical HSIL)PHASE3 · COMPLETED · started Jun 28, 2017ClinicalTrials.gov NCT03185013 · fetched Nov 12, 2026
- GLS-5700 in Dengue Virus-Naïve AdultsPHASE1 · COMPLETED · started Jul 1, 2016ClinicalTrials.gov NCT02809443 · fetched Nov 12, 2026
- Phase I, Open Label Dose Ranging Safety Study of GLS-5300 in Healthy VolunteersPHASE1 · COMPLETED · started Feb 1, 2016ClinicalTrials.gov NCT02670187 · fetched Nov 12, 2026
- Open-Label Study of INO-4212 With or Without INO-9012, Administered IM or ID Followed by Electroporation in Healthy VolunteersPHASE1 · COMPLETED · started May 1, 2015ClinicalTrials.gov NCT02464670 · fetched Nov 12, 2026
- Phase I Study of INO-1800 With or Without INO-9112 + EP in Chronic Hepatitis B SubjectsPHASE1 · COMPLETED · started Jan 12, 2015ClinicalTrials.gov NCT02431312 · fetched Nov 12, 2026
- Study of HPV Specific Immunotherapy in Participants With HPV Associated Head and Neck Squamous Cell CarcinomaPHASE1_PHASE2 · COMPLETED · started Aug 13, 2014ClinicalTrials.gov NCT02163057 · fetched Nov 12, 2026
- A Study of INO-3112 DNA Vaccine With Electroporation in Participants With Cervical CancerPHASE1_PHASE2 · COMPLETED · started Jun 6, 2014ClinicalTrials.gov NCT02172911 · fetched Nov 12, 2026
- Medpulser Electroporation With Bleomycin Study to Treat Posterior Head and Neck Squamous Cell CarcinomaPHASE3 · TERMINATED · started Nov 1, 2004ClinicalTrials.gov NCT00198328 · fetched Nov 12, 2026
- Medpulser Electroporation With Bleomycin Study to Treat Anterior Head and Neck Squamous Cell CarcinomaPHASE3 · TERMINATED · started Jun 1, 2004ClinicalTrials.gov NCT00198315 · fetched Nov 12, 2026
SEC filings12
- 8-K · 8-KSEC EDGAR · filed Nov 10, 2026 · fetched Nov 12, 2026
- 10-Q · 10-QSEC EDGAR · filed Nov 10, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Nov 9, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Nov 5, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Nov 2, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Oct 6, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Aug 12, 2026 · fetched Nov 12, 2026
- 10-Q · 10-QSEC EDGAR · filed Aug 12, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Jul 31, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Jul 29, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed May 20, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed May 13, 2026 · fetched Nov 12, 2026